ArticleCancer reports (Hoboken, N.J.)2024

Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.

Hideko Ohama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.